By encapsulating bilirubin within tiny nanoparticles, researchers have improved the survival rates of pancreatic islet cells in vitro in a low-oxygen environment. The work has implications for the treatment of Type 1 diabetes in both canine and human patients.
No comments:
Post a Comment